Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Keunchil Park, Jong-Seok Lee, Ki Hyeong Lee, Joo-Hang Kim, Byoung Chul Cho, Young Joo Min, Jae Yong Cho, Ji-Youn Han, Bong-Seog Kim, Jin-Soo Kim, Dae Ho Lee, Jin Hyoung Kang, Eun Kyung Cho, Hoon-Gu Kim, Kyung Hee Lee, Hoon Kyo Kim, In-Jin Jang et al | ||||||||||||
Title | BI 1482694 (HM61713), an EGFR mutant-specific inhibitor, in T790M+ NSCLC: Efficacy and safety at the RP2D. | ||||||||||||
|
|||||||||||||
URL | https://ascopubs.org/doi/10.1200/JCO.2016.34.15_suppl.9055 | ||||||||||||
Abstract Text | J Clin Oncol 34, 2016 (suppl; abstr 9055) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|